Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study
Fig 2
Tree-based classification model luminal A patients (n = 4570) demonstrates the application of Adjuvant Systemic Therapy (AST), Hormonal Therapy (H) and Chemotherapy (C) depending on the size of the primary tumor in millimetres.